ArticleAbdominal radiology (New York)2026
Ultrasound-guided percutaneous microwave ablation assisted by a three-dimensional visualization treatment platform (3DVOPS) for large uterine fibroids.
Article in Abdominal radiology (New York), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Efficacy of ultrasound-guided microwave ablation combined with chemical ablation for uterine fibroid management.Frontiers in oncology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study aims to evaluate the efficacy of a three-dimensional visualization operative planning system (3DVOPS) in ultrasound-guided percutaneous microwave ablation (US-PMWA) for the treatment of large uterine fibroids.
methodsFrom October 2020 to December 2023, a total of 30 patients with symptomatic uterine fibroids (≥ 7 cm) who underwent US-PMWA with the assistance of a 3D visualization operative planning system were included in this retrospective study. A control group of 60 patients who underwent US-PMWA using conventional 2D image operative planning methods was also studied. Assessment endpoints included technical efficacy and complications.
resultsThe ablation time and energy consumption in the 3D group were significantly lower than those in the 2D group (45.2 ± 7.5 min vs. 56.6 ± 8.9 min and 77.5 ± 19.3 kJ vs. 100.9 ± 36.7 kJ, respectively; P < 0.05). There was no significant difference in the ablation rate between the two groups. The incidence of vaginal discharge after ablation was lower in the 3D group compared to the 2D group (6.6% vs. 13.3%, P < 0.05). No severe complications were reported during the follow-up period.
conclusionsThe 3DVOPS can reduce ablation time and microwave energy requirements for the treatment of large uterine fibroids via US-PMWA, while also enhancing the accuracy of ablation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.